Walking in front of the new bureau 丨 expand the new pharmaceutical Zibo new pharmaceutical auxiliary materials global leading

□ Zibo Daily/Zibo Evening News/Expo News

Reporter Yang Qiuyun

New access to new medicine, new medicine stride for new journey. On August 20, the 3rd Circular Essential Academic Conference and High -end Preparation Innovation Conference were held in Zibo. Nearly 200 high -level experts and professors from all over the country and representatives of pharmaceutical companies attended the meeting. The reporter learned from the meeting that the achievements of the new pharmaceutical auxiliary materials developed by Zibo Qianhui Biotechnology Co., Ltd. (referred to as Qianhui Biological) are global, and will help the new pharmaceutical industry in my country to help the pyramid.

When it comes to cyclic paste, it is really inseparable from it in daily life. Circular paste is mainly used in the fields of medicinal accessories and food manufacturing. The conference aims to promote the innovation and industrial development of the field of medicinal auxiliary materials such as cyclic paste. In recent years, the country has continuously introduced policies to encourage drug innovation. Innovative drugs with high -tech barriers have become the research and development direction of pharmaceutical companies. Innovative medicines are inseparable from the help of high -end new accessories. Need to go together.

As one of the organizers of this conference, Qianhui Biological is a production enterprise that is mainly engaged in cyclical and derivatives. Take the Qianhui Biological New Pharmaceutical Accessible Snamed Sodium Sodium Sodium, which is the first domestic company that has passed related technical reviews. Gama Wastel has achieved its first registration at the National Pharmaceutical Review Center and the United States FDA, which has obtained a new auxiliary material pass, and innovative products like this will be born in Qianhui Bio every year.

"For example, more than 40 of the top 100 pharmaceutical companies such as Qilu Pharmaceutical and Jiangsu Yangzi are our partners. The products that have not been developed for 10 years have not been developed, and we have taken it in 5 years!" Wang Liping said with confidence that insisting on innovation has made it a supplier of well -known pharmaceutical companies in the country and even the world. In May next year, Qianhui Bio has an annual output of 1,000 tons of circular paste -essence series of auxiliary materials expansion projects to be completed and put into operation. Development to increase the development of the city's pharmaceutical industry.

Zibo is a large pharmaceutical market. The pharmaceutical industry has a history of nearly 80 years. It is the national torch plan biopharmaceutical industry base and major domestic chemical raw material pharmaceutical production base. It is the largest medical equipment and pharmacy production base in the province. In the first half of this year, our province was approved by 61 new products listed, ranking second in the country. It has obtained A -level equal times in the national pharmaceutical safety assessment for three consecutive years, creating a good and stable environment for the high -quality development of the pharmaceutical industry.

In recent years, Zibo has cultivated the new medicine as the "semi -finals" industry to cultivate and develop, forming a complete industrial chain system from fine chemical, pharmaceutical intermediates, pharmaceutical equipment, medicinal packaging materials, raw materials to preparations, etc. Relying on the traditional industrial foundation of Zibo Pharmaceutical and the concentrated advantages of the industrial chain, it has developed vigorously, and has formed a number of domestic advantages areas dominated by cyclical and cellulose. A leading company in the circular paste industry, which is dominated by Qianhui Bio. According to the relevant person in charge, the "China Huanzi Essence Academic Symposium and High -end Preparation Innovation Conference" held on the same day has been successfully held in Zibo for two sessions. The "specialized new" exchange platform has gathered and integrated the development resources of the domestic advanced pharmaceutical industry.

It is estimated that in 2023, the global pharmaceutical auxiliary materials market size is expected to reach 85.3 billion yuan, and my country's pharmaceutical auxiliary materials market will usher in broad development space. The successful holding of this conference will help the healthy development of Zibo, Shandong and even the national pharmaceutical industry, and enhance the comprehensive competitiveness of the city's pharmaceutical auxiliary materials and preparation industries.

The conference was hosted by the Zibo Municipal People's Government, the China Drug Administration Research Association, etc., and organized by the Zibo Industrial and Information Technology Bureau, the Zibo High -tech Zone Management Committee, the Zibo Non -public Economic Development Center, and Zibo Qianhui Biotechnology Co., Ltd.

- END -